SB Therapy
ActiveSummary
SB Therapy has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €423,722 and a net result of €129,248. Equity is growing by about 55% per year across the filed financial years. The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
financial year 2025 · micro format · 31 days late
26-08
Gazette deed
Registered office · Amendment of the articles · NameRegistered-office move · Name change3 facts ▸
Gazette deed
Registered office · Amendment of the articles · Name
Registered-office move · Name change3 facts ▸
- General meeting, 19-08-2026
- Registered-office move, Clos des Pleurotes 1, 1070 Anderlecht
- Name change, SB Therapy
2025
21-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 21 days late
2024
31-12
Financial
Highest result from 2022 to 2025net €136,472 ▲56.6%
Operating result €178,092, net result €136,472, both a record.
31-12
Financial
Liquidity quadruplescurrent ratio 141.81
Current ratio from 35.41 to 141.81; short-term debt falls from €4,474 to €2,055.
31-12
Financial
Equity above €200,000equity €294,474 ▲86.4%
A profit in every financial year since 2022 builds equity to €294,474.
31-07
NBB filing
Annual accounts filed
financial year 2023 · micro format
2023
31-12
Financial
Equity above €150,000equity €158,002 ▲123%
A profit in every financial year since 2022 builds equity to €158,002.
23-08
NBB filing
Annual accounts filed
financial year 2022 · micro format · 23 days late
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.